Saturday, April 22, 2017 9:12:10 AM
Welcome newbie110, pretty much says it all. This company preys on new folks who are unaware/uninformed. But what you call an opinion, I call a conclusion. I'll copy and paste their previous "big news" and you can evaluate accordingly...KEEP IN MIND, THERE ARE SOOOOOO MANY OTHERS I COULD POST, THESE ARE JUST A FEW.
WASTED GRANTS:
http://www.biospace.com/News/sunshine-biopharma-inc-parent-company-receives/305666 (interesting their parents company receives the money for Adva-27a, hmmmmmmm)but you can see, they reference over 1.45mill, zero to show for it.
http://www.marketwired.com/press-release/sunshine-biopharma-secures-funding-its-adva-27a-anticancer-compound-from-dutchess-opportunity-otcqb-sbfm-1903980.htm (previous posts asking Dutchess if they ever got anything in return from Sunshine. They stated they took the money and ran).
DEL/DIN:
https://www.accesswire.com/viewarticle.aspx?id=419414 (2014)
http://www.marketwired.com/press-release/sunshine-biopharmas-wholly-owned-canadian-subsidiary-completes-sops-required-health??)
https://www.accesswire.com/450735/Sunshine-Biopharma-Signs-Strategic-Alliance-Agreement-with-Atlas-Pharma (Ive reached out to Atlas, havent received anything back, guessing sunshine paid them stock to use their name, no such agreement exists).
Make your own conclusions, there is so much more I could post, I wont even start about Adva-27a, even they stopped touting that failure. It's run by three clever Canadians who use it to scam shareholders, and pay themselves a nice salary by selling/diluting it. All their business is done with shares, they don't pay for anything, as they have no money. So you will see this stock go up quickly (as the folks they sold their shares to make some money) then down quickly, as those folks sell of their stock to make their money back. They are literally operating SBFM as their own personal bank.SBFM will not accomplish anything, they won't sell drugs, they will never even have a drug license. It's literally the equivalent of stocking a bar, but not purchasing an alcohol license. USELESS. They will always keep the carrot dangling in front of you. They are running out of lies, luckily...
Only way they might get anywhere with health Canada would be spending money, and that money would be taken out of their unjustified salaries, so you can bet, that wont be happening, and since they have wasted so much funding and/or grants, they wont be getting those anytime soon either.
Call Camille, ask him why he feels he deserves his salary, ask him why they are letting Adva go dormant, ask him when a drug license will be up and running, been 3 years since the paperwork was compiled (according to them), ask him why no one is ever at their office, ask him what the future plan is......you are an investor, you deserve answers, it's what he pays himself 6 figures a year to do. I've never gotten an answer back from him on anything (and I was an investor at the time), I'd go up one side of him and down the other, he would have a hard time lieing to me, but good luck, hopefully my "opinions" don't get in the way of your personal due diligence. If you want my opinion, SELL, immediately!!!
WASTED GRANTS:
http://www.biospace.com/News/sunshine-biopharma-inc-parent-company-receives/305666 (interesting their parents company receives the money for Adva-27a, hmmmmmmm)but you can see, they reference over 1.45mill, zero to show for it.
http://www.marketwired.com/press-release/sunshine-biopharma-secures-funding-its-adva-27a-anticancer-compound-from-dutchess-opportunity-otcqb-sbfm-1903980.htm (previous posts asking Dutchess if they ever got anything in return from Sunshine. They stated they took the money and ran).
DEL/DIN:
https://www.accesswire.com/viewarticle.aspx?id=419414 (2014)
http://www.marketwired.com/press-release/sunshine-biopharmas-wholly-owned-canadian-subsidiary-completes-sops-required-health??)
https://www.accesswire.com/450735/Sunshine-Biopharma-Signs-Strategic-Alliance-Agreement-with-Atlas-Pharma (Ive reached out to Atlas, havent received anything back, guessing sunshine paid them stock to use their name, no such agreement exists).
Make your own conclusions, there is so much more I could post, I wont even start about Adva-27a, even they stopped touting that failure. It's run by three clever Canadians who use it to scam shareholders, and pay themselves a nice salary by selling/diluting it. All their business is done with shares, they don't pay for anything, as they have no money. So you will see this stock go up quickly (as the folks they sold their shares to make some money) then down quickly, as those folks sell of their stock to make their money back. They are literally operating SBFM as their own personal bank.SBFM will not accomplish anything, they won't sell drugs, they will never even have a drug license. It's literally the equivalent of stocking a bar, but not purchasing an alcohol license. USELESS. They will always keep the carrot dangling in front of you. They are running out of lies, luckily...
Only way they might get anywhere with health Canada would be spending money, and that money would be taken out of their unjustified salaries, so you can bet, that wont be happening, and since they have wasted so much funding and/or grants, they wont be getting those anytime soon either.
Call Camille, ask him why he feels he deserves his salary, ask him why they are letting Adva go dormant, ask him when a drug license will be up and running, been 3 years since the paperwork was compiled (according to them), ask him why no one is ever at their office, ask him what the future plan is......you are an investor, you deserve answers, it's what he pays himself 6 figures a year to do. I've never gotten an answer back from him on anything (and I was an investor at the time), I'd go up one side of him and down the other, he would have a hard time lieing to me, but good luck, hopefully my "opinions" don't get in the way of your personal due diligence. If you want my opinion, SELL, immediately!!!
Recent SBFM News
- Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) • ACCESS Newswire • 06/01/2026 12:00:00 PM
- Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology • ACCESS Newswire • 05/29/2026 12:00:00 PM
- Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing • ACCESS Newswire • 05/28/2026 01:00:00 PM
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
